Pfizer (PFE) Among Best Medical Stocks Under $30 to Invest In?

Pfizer Inc. (NYSE:PFE) is one of the 10 Best Medical Stocks to Buy Under $30. On April 20, Pfizer Inc. (NYSE:PFE) announced, together with Astellas Pharma Inc., that the US Food and Drug Administration has accepted a supplemental Biologics License Application (sBLA) for Priority Review.

The application is for the use of PADCEV (enfortumab vedotin-ejfv) in combination with the PD-1 inhibitor Keytruda (pembrolizumab), or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph), as a perioperative treatment, given before and after surgery, for patients with muscle-invasive bladder cancer (MIBC).

Pfizer (PFE) Among Best Medical Stocks to Invest In Under $30?

This regimen was already approved by the FDA in November 2025 for patients with MIBC who are not eligible for cisplatin. The new application aims to expand the indication to patients with MIBC, regardless of whether they are eligible for cisplatin or not.

According to the report by Pfizer Inc. (NYSE:PFE), the FDA grants Priority Review to medicines that may offer major improvements in treatment or address conditions where there are limited therapy options. Under the Prescription Drug User Fee Act (PDUFA), a target action date of August 17, 2026, has been set by the FDA.

Pfizer Inc. (NYSE:PFE) is a leading pharmaceutical company that focuses on the discovery, development, and manufacture of healthcare products, medicines, and vaccines.

While we acknowledge the risk and potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PFE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Fintech Stocks to Invest In According to Billionaires and 10 Unrivaled Stocks of the Next 5 Years.

Disclosure: None.  Follow Insider Monkey on Google News.